Hansa Biopharma AB (HNSBF)
2.90
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Hansa Biopharma Total Liabilities (Quarterly) : 150.89M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 150.89M |
| December 31, 2025 | 136.22M |
| September 30, 2025 | 138.42M |
| June 30, 2025 | 134.13M |
| March 31, 2025 | 132.30M |
| December 31, 2024 | 125.84M |
| September 30, 2024 | 124.36M |
| June 30, 2024 | 117.86M |
| March 31, 2024 | 112.67M |
| December 31, 2023 | 117.68M |
| September 30, 2023 | 113.52M |
| June 30, 2023 | 109.28M |
| March 31, 2023 | 104.64M |
| December 31, 2022 | 104.08M |
| September 30, 2022 | 93.37M |
| June 30, 2022 | 29.56M |
| March 31, 2022 | 27.20M |
| December 31, 2021 | 28.19M |
| September 30, 2021 | 22.03M |
| June 30, 2021 | 21.87M |
| March 31, 2021 | 18.46M |
| December 31, 2020 | 23.42M |
| September 30, 2020 | 21.04M |
| Date | Value |
|---|---|
| June 30, 2020 | 8.768M |
| March 31, 2020 | 6.615M |
| December 31, 2019 | 10.83M |
| September 30, 2019 | 6.839M |
| June 30, 2019 | 6.727M |
| March 31, 2019 | 6.788M |
| December 31, 2018 | 9.581M |
| September 30, 2018 | 7.161M |
| June 30, 2018 | 6.810M |
| March 31, 2018 | 6.642M |
| December 31, 2017 | 6.077M |
| September 30, 2017 | 3.311M |
| June 30, 2017 | 3.583M |
| March 31, 2017 | 2.922M |
| December 31, 2016 | 2.970M |
| September 30, 2016 | 2.331M |
| June 30, 2016 | 2.481M |
| March 31, 2016 | 1.614M |
| December 31, 2015 | 1.49M |
| September 30, 2015 | 1.176M |
| June 30, 2015 | 1.519M |
| March 31, 2015 | 1.744M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioArctic AB | 50.51M |
| Swedish Orphan Biovitrum AB | 4.291B |
| Diamyd Medical AB | 9.292M |
| BONESUPPORT HOLDING AB | 18.89M |
| BioInvent International AB | 10.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Shareholders Equity (Quarterly) | -28.90M |
| Debt to Equity Ratio | -4.150 |
| Current Ratio | 3.630 |
| Net Debt Paydown Yield | -1.54% |